(Bloomberg) -- At a hearing that kicked off on Wednesday, a Belgian court is weighing EU claims that there’s an emergency situation that merits an order for the drug maker to deliver 20 million more shots than it has promised so far by the end of June. The same court will examine later this year whether Astrazeneca violated the terms of its contract.
“Astrazeneca hasn’t even tried to use all of the tools at its disposal,” the European Commission’s lawyer Rafael Jafferali told a court hearing in Brussels on Wednesday, referring to six production sites in the region that could be used to make deliveries to the EU. The company’s record so far is “obviously a failure.”
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.